March 2020 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2020. This roundup includes...
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Severe COVID-19 Risk Up With Existing Health Conditions in U.S.
Most commonly reported underlying health conditions were diabetes, chronic lung disease, CVD
ENDO: Diabetes Diminishes Weight Loss Effect of Bariatric Surgery
Those without diabetes had increased odds of achieving 50 percent or more excess body-weight loss
ENDO: Real-World Data Analyzed for Use of Insulin Pump in T1DM
Subgroup analysis shows time spent in target glucose range increased in auto mode versus manual mode
Doctors, Hospitals, Pharmacies Warned Not to Stockpile Meds
Professional societies issue stern warning not to inappropriately prescribe meds for COVID-19
ENDO: Thyroid Hormone Use May Up Mortality Risk in Older Adults
Increased risk for death seen for visits on LT4 versus those with isolated elevated TSH who were untreated
Consistent Sleep in Early Adulthood May Cut Diabetes Risk
Findings seen in women; associations weakened after adjusting for obesity, other metabolic comorbidities
ENDO: HbA1c Tied to Cognition in T2DM Patients After Lacunar Stroke
Increase in HbA1c over time linked to decrease in Cognitive Assessment Screening Instrument score
U.S. Army Opens Field Hospital in New York City
Field hospital in Manhattan meant to handle non-COVID-19 patients to free up space in city hospitals
